New CEO expects an exciting ride At Lycera Crain's Detroit business concern Lycera Corp., a spinoff from the University of Michigan that is nonindustrial drugs to fight specified autoimmune diseases as lupus, rheumatoid arthritis and disease of the skin , first made ample headlines in April 2009 when it announced it had closed on type A Series A round ... Link To Article
No comments:
Post a Comment